A Phase 2 Randomized, Double-Blind, Placebo-Controlled, 2-Arm, Multi-Center Study Comparing Tivozanib Hydrochloride In Combination With Paclitaxel Versus Placebo In Combination With Paclitaxel in the Treatment of Subjects With Locally Recurrent and/or Met
Read time: 1 mins
Last updated:28th Mar 2013
To compare progression free survival (PFS) of subjects treated with tivozanib hydrochloride in combination with paclitaxel vs subjects treated with placebo in combination with paclitaxel.
|Study start date||2013-03-28|